Acacia Research Corporation (NASDAQ:
ACTG) announced today that a
subsidiary has acquired patents relating to vascular device technology.
“Acacia and its subsidiaries continue to increase the number of patent
portfolios they control in the medical device and diagnostics sectors,”
commented Paul Ryan, CEO.
See full press release© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
